| 前收市價 | 0.5500 |
| 開市 | 0.6000 |
| 買盤 | 0.4500 |
| 賣出價 | 0.7000 |
| 拍板 | 5.00 |
| 到期日 | 2024-05-17 |
| 今日波幅 | 0.6000 - 0.6000 |
| 合同範圍 | 無 |
| 成交量 | |
| 未平倉合約 | 282 |
Insider MonkeyPuma Biotechnology, Inc. (NASDAQ:PBYI) Q1 2024 Earnings Call Transcript
Puma Biotechnology, Inc. (NASDAQ:PBYI) Q1 2024 Earnings Call Transcript May 2, 2024 Puma Biotechnology, Inc. beats earnings expectations. Reported EPS is $-0.05, expectations were $-0.16. PBYI isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon. My name is Camilla, […]
ZacksPuma Biotechnology's (PBYI) Q1 Earnings and Revenues Beat
Puma Biotechnology (PBYI) reports narrower-than-expected first-quarter 2024 loss. The company maintains its revenue guidance for 2024.
ZacksWhat's in Store for Puma Biotechnology (PBYI) in Q1 Earnings?
On Puma Biotechnology's (PBYI) first-quarter 2024 earnings call, investors' focus is likely to be on the sales performance of its sole marketed cancer drug, Nerlynx.
